For the possible significance see Oral bacteria relative abundance in faeces increases due to gut microbiota depletion and is linked with patient outcomes, 2024
| "Ristella oralis" (Loesche et al. 1964) Prevot et al. 1967| ATCC 33269| Bacteroides oralis| Bacteroides oralis Loesche et al. 1964 (Approved Lists 1980)| CCUG 15408| DSM 20702| JCM 12251| NCTC 11459| Prevotella oralis| Prevotella oralis (Loesche et al. 1964) Shah and Collins 1990 emend. Hahnke et al. 2016| Ristella oralis| VPI D27B-24
Oral microbiota: Hoylesella oralis is commonly found in the oral cavity, particularly in dental plaque and saliva. It is considered a commensal bacterium, meaning it typically coexists with other microorganisms in the mouth without causing disease. However, disruptions in the balance of the oral microbiota, including changes in the abundance of Hoylesella oralis, have been associated with oral health conditions such as dental caries (cavities), periodontal disease (gum disease), and halitosis (bad breath).
Gut microbiota: While less studied in comparison to its presence in the oral cavity, Hoylesella species, including Hoylesella oralis, have also been detected in the gastrointestinal tract. The role of Hoylesella species in the gut microbiota and their potential impacts on gut health are still being elucidated. Some studies suggest that alterations in the gut microbiota composition, including changes in the abundance of Hoylesella species, may be associated with gastrointestinal disorders such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). However, more research is needed to understand the specific contributions of Hoylesella oralis to gut health and disease.
Metabolic health: Some studies have suggested associations between the presence of Hoylesella species in the gut microbiota and metabolic health outcomes, such as obesity and metabolic syndrome. However, the nature of these associations and the mechanisms underlying them are not fully understood. Further research is needed to determine whether specific Hoylesella species, including Hoylesella oralis, play a causal role in metabolic disorders or are simply markers of dysbiosis (imbalances in the gut microbiota) associated with these conditions.
Probiotic potential: Like other commensal bacteria, certain strains of Hoylesella species may have probiotic potential, meaning they could confer health benefits when consumed in adequate amounts. Probiotics containing strains of Hoylesella species, including Hoylesella oralis, are being investigated for their potential to support oral and gut health, modulate the immune system, and promote overall well-being. However, more research is needed to evaluate the efficacy and safety of probiotic formulations containing Hoylesella species.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 16.24 | 0 | 10 | 1 | 420 | 0 | 5042 | 272.9 | 34 | 2433.3 | 6 | 126 | 0 %ile | 95 %ile |
biomesight | 0.71 | 10 | 750 | 0 | 416 | 71.2 | 30 | 175.8 | 10 | 750 | 0 %ile | 100 %ile | ||
thryve | 32.4 | 0 | 19 | 1 | 382 | 0 | 5106 | 277.8 | 38 | 2463.3 | 4 | 124 | 0 %ile | 95 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSight | 0.854 % | 0.018 % | 0.069 % | 31.0 | 3631 |
Thryve | 31.918 % | 0.025 % | 0.217 % | 466.0 | 1460 |
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2024 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription
All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [98.80.143 ]
Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [98.80.143 ]